
---
title: '呼吸道合胞病毒疫苗和单抗最新研究进展（3）'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=947415'
author: 科学网
comments: false
date: Mon, 15 Aug 2022 15:42:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=947415'
---

<div>   
<p><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"></span></strong></p><p style="margin: 18px 0;text-indent: 0;padding: 0;line-height: 28px;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 35px">呼吸道合</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 35px"><span style="font-family:Shaker2Lancet-Bold">胞病毒预防制剂曙光在前</span>:　</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 35px">疫苗和单克隆抗体百舸争流</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">前言：</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">　　新冠病毒大流行的将近３年，也是世界疫苗行业突飞猛进、疫苗研发技术日新月异、硕果累累的３年。疫苗制备的多种技术途径都得到深度开发，若干种新兴的技术途径如</span><span style="font-family:Microsoft YaHei UI">mRNA疫苗获得了空前的成功，在世界各地大行其道，在多种传染病以及癌症和其他慢性病的防治领域都在不断开花结果。</span></span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong>　　</strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">呼吸道合胞病毒（</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px">Respiratory syncytial virus，</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">）</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">是一种历史悠久、危害极大的传染病，其疫苗的研发已经有四十年的历史，</span><span style="font-family:Microsoft YaHei UI"> 但最初开发的疫苗反而会引发</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">疫苗相关性呼吸道疾病（</span><span style="font-family:Microsoft YaHei UI">VAERD，Vaccine-associated enhanced respiratory diseases</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">）</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">，即未接触过</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">的儿童在接种了疫苗后，如果再接触到该病毒反而会发生更严重的</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">疾病。诸如此类的问题导致针对</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">的疫苗一直未能上市。乘新冠病毒疫苗大跃进的东风，已赚得盆满钵满的疫苗巨头如</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">辉瑞（</span><span style="font-family:Microsoft YaHei UI">Pfizer)</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">、</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">莫德纳（</span><span style="font-family:Microsoft YaHei UI">Moderna</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">）和</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">葛兰素史克</span><span style="font-family:Microsoft YaHei UI">(GSK)</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">等目前都在</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">的疫苗开发上快马加鞭，有望在较短时间内取得重大突破。</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong>　　</strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">疫苗和单克隆抗体研究领域来自世界各地的顶级研究人员（约５０人）近期联名在国际著名专业杂志《</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #FF0000;letter-spacing: 0;font-size: 24px">Lancet</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"> Infect Dis》上发表综述论文，介绍相关最新研究进展（见</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #222222;letter-spacing: 0;font-size: 24px">参考文献</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">），本博客将分数次介绍此综述的主要内容。</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 29px">目录：</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px">摘要</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">一</span>.　前言</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">二</span>.　方法</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">三</span>.　教训（Lessons learned）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">四</span>.　活的减毒疫苗（liveattenuated vaccines，LAVs ）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">五</span>.　嵌合疫苗（Chimeric ）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">六</span>.　亚单位疫苗（Subunit）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">七</span>.　基于颗粒的疫苗（Particle-based ）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">八</span>.　核酸疫苗（Nucleic acid）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">九</span>.　重组载体疫苗（Recombinant vectors）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">十</span>.　单克隆抗体（MAbs）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">十一</span>.　讨论 </span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:24px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px"><br></span></strong></p><p style="margin-top: 14px;margin-left: 0;text-indent: 0;background: rgb(255, 255, 255)"><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px"><span style="font-family:sans-serif">图</span>1:</span></strong><strong>　</strong><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">儿</span></strong><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">童</span></strong><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">RSV(</span></strong><span style="font-family: 'Microsoft YaHei';color: #2A2B2E;letter-spacing: 0;font-size: 24px">呼吸道合胞病毒</span><span style="font-family: 'Microsoft YaHei';color: #2A2B2E;letter-spacing: 0;font-size: 24px">)</span><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">疾病负担的关键事实和数据</span></strong></p><p><span style="font-family: SimSun;"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=947415" title alt="image.png" width="1" height="1" style="width: 1px; height: 1px;" referrerpolicy="no-referrer"> <img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=947417" title alt="image.png" width="720" height="984" style="width: 720px; height: 984px;" referrerpolicy="no-referrer"></span></p><p><span style=";font-family:SimSun;font-size:16px"> </span></p><p><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">Figure 1</span></strong><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">：</span></strong><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">Paediatric RSV disease burden key facts and figures</span></strong></p><p style="margin-top: 10px;margin-bottom: 18px;background: rgb(255, 255, 255)"><span style="color: #505050;letter-spacing: 0;font-weight: bold;font-size: 24px">(A) </span><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">RSV对全球肺炎的贡献:</span></strong></p><p style="margin-top: 10px;margin-bottom: 18px;background: rgb(255, 255, 255)"><span style="color: #505050; letter-spacing: 0px; font-size: 21px; font-family: sans-serif;">　　</span><span style="color: #FF0000;"><strong><span style="letter-spacing: 0px; font-size: 21px;"><span style="font-family: sans-serif;">全球约三分之一</span>(31％)的肺炎是由RSV引起的。</span></strong></span></p><p style="margin-top: 10px;margin-bottom: 18px;background: rgb(255, 255, 255)">　　　<span style="color: #505050;letter-spacing: 0;font-size: 21px">RSV</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">每年在全球引起</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">3</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">,300</span><span style="color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">万例急性呼吸道感染，其中</span><span style="font-family:sans-serif">310万人住院、11.82万人死亡。</span></span></p><p style="margin-top: 10px;margin-bottom: 18px;margin-left: 0;text-indent: 0;background: rgb(255, 255, 255)"><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">(B) 与RSV相关的死亡</span></strong><strong><span style="color: #505050;letter-spacing: 0;font-size: 21px">:</span></strong></p><p style="margin-top: 10px;margin-bottom: 18px;margin-left: 0;text-indent: 0;background: rgb(255, 255, 255)"><span style="color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">　　全球</span>99%以上的RSV引起的儿童死亡负担发生在</span><span style="text-decoration: underline;"><span style="text-decoration: underline; color: #505050; letter-spacing: 0px; font-size: 21px;">低收入和中等收入国家</span><span style="text-decoration: underline; font-family: SimSun; color: #505050; letter-spacing: 0px; font-size: 21px;"><span style="text-decoration: underline; font-family: SimSun;">（</span><span style="text-decoration: underline; font-family: sans-serif;">LMICs</span><span style="text-decoration: underline; font-family: SimSun;">）</span></span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px">。</span></p><p style="margin-top: 10px;margin-bottom: 18px;margin-left: 0;text-indent: 0;background: rgb(255, 255, 255)">　　　<span style="color: #505050;letter-spacing: 0;font-size: 21px">获得</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">医疗</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">护理</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">的机会</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">可能是死亡率负担分</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">担</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">不公平的一个关键因素，因为这些儿童中只有不到四分之一</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">（</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">24</span></span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">％）</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">能获得重症护理。</span></p><p style="margin-top: 10px;margin-bottom: 18px"><span style="color: #505050;letter-spacing: 0;font-size: 21px;background: #FFFFFF"> </span><span style="color: #505050;letter-spacing: 0;font-size: 21px;background: #FFFFFF">　　</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">至少有一半</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">（</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">50</span><span style="font-family:SimSun">％－</span><span style="font-family:sans-serif">80</span><span style="font-family:SimSun">％）</span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px">的负担被</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">忽略</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">,这些死亡发生在医院之外。</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">近期</span><span style="color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">医院外负担的特点是</span>,与医院</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">内</span><span style="color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">死亡率的负担不同</span>,它对全球疫苗发展有影响:死于医院</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">外</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">的儿童</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">的年龄更小，在医院内死亡婴儿的平均年龄是</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">2.4</span><span style="font-family:SimSun">个月，在医院外死亡婴儿的平均年龄只有</span><span style="font-family:sans-serif">1.5</span><span style="font-family:SimSun">个月。</span></span></p><p style="margin-top: 10px;margin-bottom: 18px;margin-left: 0;text-indent: 0;background: rgb(255, 255, 255)">　　　<span style="color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">危险因素与贫困有关</span>,而</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">与</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">潜在的</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">医疗</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">条件</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">无关</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">。</span></p><p style="margin-top: 10px;margin-bottom: 18px;margin-left: 0;text-indent: 0;background: rgb(255, 255, 255)"><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">(C) 总费用:　</span></strong></p><p style="margin-top: 10px;margin-bottom: 18px;margin-left: 0;text-indent: 0;background: rgb(255, 255, 255)"><span style="color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">　　在低收入和中等收入国家，与</span>RSV直接相关的费用估计</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">为</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">3</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">1.3</span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">亿美元</span> (95% CI 2·27–5·13)，还有额外8·7%的直接</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">的</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">非医疗</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">费用</span><span style="color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">和</span>36·7%</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">的</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">间接费用。</span></p><p style="margin-top: 10px;margin-bottom: 18px"><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:sans-serif"><strong style="white-space: normal;"><span style="background: #FFFFFF; font-family: sans-serif; color: #505050; letter-spacing: 0px; font-size: 24px;">(D) </span></strong></span></span></strong><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">成本效益和</span></strong><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">潜在</span></strong><strong><span style="color: #505050;letter-spacing: 0;font-size: 24px">效益可用下列数据来估算。</span></strong></p><p style="margin-top: 10px; margin-bottom: 18px; margin-left: 0px; text-indent: 0px; background: rgb(255, 255, 255);"><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">　　</span><span style="font-family: SimSun; color: #505050; letter-spacing: 0px; font-size: 21px; text-decoration: underline;"><strong>孕产妇疫苗</strong></span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">每年平均可</span><span style="color: #505050;letter-spacing: 0;font-size: 21px">避免</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">3,000</span><span style="font-family:SimSun">人</span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px"> (95% CI 1,000–11,000)<span style="color: #505050; font-size: 21px; background-color: #FFFFFF;">死亡</span></span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">，可节约的</span><span style="text-decoration: underline;"><span style="text-decoration: underline; color: #505050; letter-spacing: 0px; font-size: 21px;">残疾调整生命年</span><span style="text-decoration: underline; font-family: SimSun; color: #505050; letter-spacing: 0px; font-size: 21px;"><span style="text-decoration: underline; font-family: SimSun;">（</span><span style="text-decoration: underline; font-family: sans-serif;">DALYs</span><span style="text-decoration: underline; font-family: SimSun;">，</span></span><span style="text-decoration: underline; color: #505050; letter-spacing: 0px; font-size: 21px;">disability adjusted life-years.</span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px">）</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">为<span style="font-family:sans-serif">98</span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px">,</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">000</span><span style="font-family:SimSun">年</span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px">，</span><span style="text-decoration: underline;"><span style="text-decoration: underline; color: #505050; letter-spacing: 0px; font-size: 21px;">单克隆抗体</span><span style="text-decoration: underline; font-family: SimSun; color: #505050; letter-spacing: 0px; font-size: 21px;"><span style="text-decoration: underline; font-family: SimSun;">（</span><span style="text-decoration: underline; font-family: sans-serif;">mAbs</span></span></span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:SimSun">）每年平均可避免</span><span style="font-family:sans-serif">5</span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px">,</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">000</span><span style="font-family:SimSun">人<span style="color: #505050; font-size: 21px; background-color: #FFFFFF;">(95% CI 1,000–15,000)</span>死亡，</span>可节约的</span><span style="text-decoration: underline;"><span style="text-decoration: underline; color: #505050; letter-spacing: 0px; font-size: 21px;">残疾调整生命年</span><span style="text-decoration: underline; font-family: SimSun; color: #505050; letter-spacing: 0px; font-size: 21px;"><span style="text-decoration: underline; font-family: SimSun;">（</span><span style="text-decoration: underline; font-family: sans-serif;">DALYs</span></span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px">）</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px">为<span style="font-family:sans-serif">137</span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px">,</span><span style="font-family: SimSun;color: #505050;letter-spacing: 0;font-size: 21px"><span style="font-family:sans-serif">000</span><span style="font-family:SimSun">年</span></span><span style="color: #505050;letter-spacing: 0;font-size: 21px">。</span></p><p style="margin-top: 10px; margin-bottom: 18px; margin-left: 0px; text-indent: 0px; background: rgb(255, 255, 255);"><span style="color: #505050;letter-spacing: 0;font-size: 21px"></span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><span style="color: #505050;letter-spacing: 0;font-size: 21px"> </span><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">（未完待续）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 24px">参考文献：</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><em><span style="font-family: Shaker2Lancet-Italic;color: #006F3C;letter-spacing: 0;font-size: 20px">Natalie I Mazur,</span></em><em>　</em><em><span style="font-family: Shaker2Lancet-Italic;color: #006F3C;letter-spacing: 0;font-size: 20px">et al., </span></em><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px">Respiratory syncytial virus prevention within reach:</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px"> the vaccine and monoclonal antibody landscape, </span></strong><em><span style="font-family: Shaker2Lancet-Bold;color: #FF0000;letter-spacing: 0;font-size: 20px">Lancet Infect Dis</span></em><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px"><span style="font-family:Shaker2Lancet-Bold">，</span> Published online August 8, 2022， </span></strong><span style="font-family: Tahoma;color: #505050;letter-spacing: 0;font-size: 20px">DOI: </span><a href="https://doi.org/10.1016/S1473-3099(22)00291-2" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 20px">https://doi.org/10.1016/S1473-3099(22)00291-2</span></a><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 20px">，</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #6666CC;letter-spacing: 0;font-size: 20px">https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext</span></span></a><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px">.</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px">相关博文：</span></strong><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350903" target="_blank"></a></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350903" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=947424" title alt="image.png" referrerpolicy="no-referrer"><span style="text-decoration:underline;"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（１）</span></span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 20px"> 2022-08-12</span></p><p style="margin: 16px 0px; text-indent: 0px; padding: 0px; background: rgb(255, 255, 255);"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350986" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=947425" title alt="image.png" referrerpolicy="no-referrer"><strong><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>2）</span></strong></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-13</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-347754-1351276.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-347754-1351276.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1350986.html" target="_black">呼吸道合胞病毒疫苗和单抗最新研究进展（2）</a><br>下一篇：<a href="http://blog.sciencenet.cn/blog-347754-1351490.html" target="_black">呼吸道合胞病毒疫苗和单抗最新研究进展（4）</a>                    <!--大赛结束-->
                                        
  
</div>
            